News on protein analysis, clinical proteomics, biomarkers in genetics, genomics, and molecular diagnostics.
The company said the funds will be used to expand its management team and complete commercialization of its mass spec multinozzle emitter array technology.
The company, which has just changed its name from Sygnis, has now completed the integration of several recent acquisitions including TGR Biosciences.
The platform can now measure RNA and proteins simultaneously at the single-cell level and can multiplex more than 100 proteins per experiment, the company said.
The company has developed a DNA barcode-based screening system that it said brings development time of its PCC affinity reagents down to around two weeks.
Fluidigm reported that its mass cytometry revenues jumped 32 percent while genomics revenues fell 5 percent year over year.
National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.
NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.
The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.
In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.
This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.